Global Cell Freezing Media Industry: Key Statistics and Insights in 2024-2032

Summary:

• The global cell freezing media market size reached USD 150.8 Million in 2023.
• The market is expected to reach USD 315.5 Million by 2032, exhibiting a growth rate (CAGR) of 8.55% during 2024-2032.
• North America leads the market, accounting for the largest cell freezing media market share.
• DMSO accounts for the majority of the market share in the product segmentas it is designed to enhance cell preservation and viability during cryopreservation. 
• Stem cell lines hold the largest share in the cell freezing media industry.
• Pharmaceutical and biotechnological companies remain a dominant segment in the marketdue to the rising focus on preserving the viability and functionality of cells during cryopreservation.
• The rising demand in biobanking and cryopreservation is a primary driver of the cell freezing media market.
• Advancements in cell and gene therapies and the expansion of regenerative medicine are reshaping the cell freezing media market.

Request PDF Sample for more detailed market insights: https://www.imarcgroup.com/cell-freezing-media-market/requestsample

Industry Trends and Drivers:

• Growing Demand in Biobanking and Cryopreservation:    

Biobanking is becoming an essential tool in research, drug discovery, and personalized medicine, leading to a rise in the demand for cell freezing media. Biobanks store vast collections of biological samples, including cells, tissues, and blood, for future research and medical use. Cryopreservation is a method that uses cell freezing media to preserve the viability of these samples for a long period of time. It is crucial in maintaining the integrity of genetic material and cell functions. With growing investments in genomics and precision medicine, biobanks are becoming indispensable to support cutting-edge research in cancer, regenerative medicine, and other fields. As a result, there is an increase in the need for advanced freezing media that ensures high survival rates of cells during thawing. This expansion along with stringent quality control and regulatory standards for sample storage is supporting the market growth.

• Advancements in Cell and Gene Therapies:

The prominence of cell and gene therapies, which involve the modification or replacement of dormant cells or genes to treat diseases, is reinforcing market growth. These therapies often require storage and transportation of cells such as stem cells, immune cells or engineered tissues, which must remain viable throughout the process. Effective freezing media is essential in cryopreserving these cells without compromising their therapeutic potential. The growing demand for robust cryopreservation technologies, including specialized freezing media, due to the increasing number of cell and gene therapy clinical trials is providing a favorable market outlook. Innovations in the development of cryoprotectants that reduce ice crystal formation and minimize cell damage during freezing and thawing processes are critical to improving therapy outcomes.

• Expansion of Regenerative Medicine:  

Regenerative medicine, which focuses on the repair, replacement or regeneration of damaged cells, tissues and organs, is becoming a major driver of the cell freezing media market. Stem cell therapy, tissue engineering and organ regeneration are at the forefront of this field, which require cells to be preserved in a viable state for future therapeutic use. Effective freezing media play a vital role in ensuring the longevity and functionality of these cells. As research in regenerative medicine advances, there is a growing need for high-quality cryopreservation solutions that maintain cell potential and reduce the risk of cellular damage during storage and transportation. The growing applications of stem cells in treating chronic conditions such as neurodegenerative diseases, diabetes and cardiovascular problems are expanding the use of cryopreserved cells.

Cell Freezing Media Market Report Segmentation:

Breakup By Product:

• DMSO
• Glycerol
• Others

DMSO account for the majority of shares as it is designed to enhance cell preservation and viability during cryopreservation.  

Breakup By Application:     

• Stem Cell Lines
• Cancer Cell Lines
• Others

Stem cell lines dominate the market on account of their ability to self-renew and differentiate into several specialized cell types.

Breakup By End Use:       

• Pharmaceutical and Biotechnological Companies
• Research and Academic Institutes
• Others

Pharmaceutical and biotechnological companies represent the majority of shares due to the rising focus on preserving the viability and functionality of cells during cryopreservation.   

Breakup By Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America enjoys the leading position owing to a large market for cell freezing media driven by the presence of key market players.       

Top Cell Freezing Media Market Leaders:

The cell freezing media market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:

• AMSBIO
• BioLifeSolutions Inc
• Bio-Techne
• BPS Bioscience, Inc.
• Capricorn Scientific
• Cell Applications Inc.
• Cell Systems (AnaBios Corporation)
• HiMedia Laboratories
• Merck KGaA
• Sartorius AG
• STEMCELL Technologies
• Thermo Fisher Scientific Inc.

Note: If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most changemakers to create a lasting ambitious impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145